Gables Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.06K | Hold |
103
| – | – | ﹤0.01% | 403 |
|
|
2026
Q1 | $8.93K | Hold |
103
| – | – | ﹤0.01% | 371 |
|
|
2025
Q4 | $9.89K | Hold |
103
| – | – | ﹤0.01% | 362 |
|
|
2025
Q3 | $9.81K | Hold |
103
| – | – | ﹤0.01% | 358 |
|
|
2025
Q2 | $8.98K | Hold |
103
| – | – | ﹤0.01% | 363 |
|
|
2025
Q1 | $9.26K | Hold |
103
| – | – | ﹤0.01% | 363 |
|
|
2024
Q4 | $8.23K | Hold |
103
| – | – | ﹤0.01% | 366 |
|
|
2024
Q3 | $9.27K | Sell |
103
-186
| -64% | -$15.6K | ﹤0.01% | 371 |
|
|
2024
Q2 | $22.7K | Hold |
289
| – | – | 0.01% | 262 |
|
|
2024
Q1 | $25.2K | Hold |
289
| – | – | 0.01% | 258 |
|
|
2023
Q4 | $23.8K | Hold |
289
| – | – | 0.01% | 252 |
|
|
2023
Q3 | $22.6K | Hold |
289
| – | – | 0.02% | 236 |
|
|
2023
Q2 | $25.5K | Hold |
289
| – | – | 0.02% | 236 |
|
|
2023
Q1 | $23.3K | Hold |
289
| – | – | 0.02% | 243 |
|
|
2022
Q4 | $22.5K | Hold |
289
| – | – | 0.02% | 238 |
|
|
2022
Q3 | $23K | Sell |
289
-70
| -19% | -$6.29K | 0.02% | 235 |
|
|
2022
Q2 | $32K | Hold |
359
| – | – | 0.02% | 230 |
|
|
2022
Q1 | $40K | Hold |
359
| – | – | 0.03% | 223 |
|
|
2021
Q4 | $37K | Hold |
359
| – | – | 0.02% | 226 |
|
|
2021
Q3 | $45K | Hold |
359
| – | – | 0.03% | 205 |
|
|
2021
Q2 | $45K | Sell |
359
-122
| -25% | -$15.3K | 0.03% | 210 |
|
|
2021
Q1 | $57K | Hold |
481
| – | – | 0.03% | 208 |
|
|
2020
Q4 | $56K | Hold |
481
| – | – | 0.03% | 193 |
|
|
2020
Q3 | $50K | Buy |
+481
| New | +$48.3K | 0.03% | 198 |
|
|
2020
Q2 | – | Sell |
-411
| Closed | -$37K | – | 392 |
|
|
2020
Q1 | $37K | Buy |
411
+165
| +67% | +$17.6K | 0.03% | 204 |
|
|
2019
Q4 | $28K | Sell |
246
-1,000
| -80% | -$110K | 0.02% | 236 |
|
|
2019
Q3 | $34K | Buy |
1,246
+1,122
| +905% | +$117K | 0.02% | 233 |
|
|
2019
Q2 | $12K | Sell |
124
-150
| -55% | -$13.7K | 0.01% | 273 |
|
|
2019
Q1 | $25K | Hold |
274
| – | – | 0.02% | 230 |
|
|
2018
Q4 | $25K | Hold |
274
| – | – | 0.02% | 221 |
|
|
2018
Q3 | $27K | Hold |
274
| – | – | 0.02% | 226 |
|
|
2018
Q2 | $23K | Buy |
+274
| New | +$22.9K | 0.02% | 236 |
|
Other funds holding MDT
Gables Capital Management's MDT Position: Q2 2026 in Review
Gables Capital Management held its Medtronic (MDT) position steady in Q2 2026 at 103 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #403.
Gables Capital Management first reported a position in MDT in Q2 2018 and has held it in 32 quarters since. The position peaked at $57K in Q1 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Gables Capital Management held 103 shares of Medtronic worth $8.06K as of Q2 2026.
- Gables Capital Management left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up ﹤0.01% of Gables Capital Management's portfolio in Q2 2026, its #403 holding.
- Gables Capital Management first reported a position in Medtronic in Q2 2018 and has held it in 32 quarters since.
- Gables Capital Management's Medtronic position peaked at $57K in Q1 2021.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.